Expression of plasminogen activator-inhibitor-1 (PAI-1) during cellular remodeling in proliferative glomerulonephritis in the ratJL Barnes, RJ Mitchell and ES Torres Department of Medicine, University of Texas Health Science Center, San Antonio 78284, USA. Pericellular proteolysis involves the plasminogen activator/plasmin system and plays an important role in cell remodeling involving cell migration and extracellular matrix turnover. Studies in this laboratory have previously characterized a model of proliferative glomerulonephritis induced by Habu snake venom (HSV) in the rat that involves cell migration, proliferation, and extracellular matrix accumulation. Because plasminogen activator-inhibitor-1 (PAI-1) has been used as a marker for cell migration as well as matrix accumulation, we were interested in examining the temporal and spatial expression and cellular sources of PAI-1 mRNA and translated protein over the course of HSV-induced proliferative glomerulonephritis. The results showed a highly localized and progressive expression of PAI-1 mRNA and translated protein by in situ hybridization and immunohistochemistry at the margins and periphery of glomerular lesions 8 and 24 hr after HSV. The expression of PAI-1 in glomerular lesions localized to the same sites as mesangial cell marker proteins, desmin and Thy-1.1, indicating that mesangial cells synthesize this important regulator proteolysis. Few cells expressed PAI-1 in the central aspects of glomerular lesions at later time intervals (48 and 72 hr) when cell proliferation and expression of extracellular matrix (fibronectin protein and mRNA) were maximal. Therefore, the expression of PAI-1 in this model was associated more with early events related to cell migration than with proliferation or extracellular matrix synthesis. These observations support the hypothesis that the plasminogen activator/plasmin system is involved in cell migration in early remodeling during glomerular disease.
Volume 43,
Issue 9,
pp. 895-905,
09/01/1995
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
O. M. Steinmetz, U. Panzer, S. Fehr, C. Meyer-Schwesinger, R. A. K. Stahl, and U. O. Wenzel A pitfall of glomerular sieving: profibrotic and matrix proteins derive from the Bowman's capsule and not the glomerular tuft in rats with renovascular hypertension Nephrol. Dial. Transplant., October 1, 2007; 22(10): 3055 - 3060. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Eddy and A. B. Fogo Plasminogen Activator Inhibitor-1 in Chronic Kidney Disease: Evidence and Mechanisms of Action J. Am. Soc. Nephrol., November 1, 2006; 17(11): 2999 - 3012. [Full Text] [PDF] |
||||
![]() |
J. L. Faulkner, L. M. Szcykalski, F. Springer, and J. L. Barnes Origin of Interstitial Fibroblasts in an Accelerated Model of Angiotensin II-Induced Renal Fibrosis Am. J. Pathol., November 1, 2005; 167(5): 1193 - 1205. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Eddy Plasminogen activator inhibitor-1 and the kidney Am J Physiol Renal Physiol, August 1, 2002; 283(2): F209 - F220. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-S. HA, J. L. BARNES, J. L. STEWART, C. W. KO, J. H. MINER, D. R. ABRAHAMSON, J. R. SANES, and B. S. KASINATH Regulation of Renal Laminin in Mice with Type II Diabetes J. Am. Soc. Nephrol., September 1, 1999; 10(9): 1931 - 1939. [Abstract] [Full Text] |
||||
![]() |
V. L. Barnes, J. Musa, R. J. Mitchell, and J. L. Barnes Expression of Embryonic Fibronectin Isoform EIIIA Parallels {alpha}-Smooth Muscle Actin in Maturing and Diseased Kidney J. Histochem. Cytochem., June 1, 1999; 47(6): 787 - 798. [Abstract] [Full Text] |
||||
![]() |
J. L. Barnes, R. J. Mitchell, J. J. Kanalas, and V. L. Barnes Differential Expression of Thrombospondin and Cellular Fibronectin During Remodeling in Proliferative Glomerulonephritis J. Histochem. Cytochem., April 1, 1999; 47(4): 533 - 544. [Abstract] [Full Text] |
||||
![]() |
D. P. Basile, D. R. Martin, and M. R. Hammerman Extracellular matrix-related genes in kidney after ischemic injury: potential role for TGF-beta in repair Am J Physiol Renal Physiol, December 1, 1998; 275(6): F894 - F903. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Emert, C. M. Sorenson, D. P. Basile, J. G. Rogers, M. R. Hammerman, and J. J. Billadello The human plasminogen activator inhibitor type I gene promoter targets to kidney Am J Physiol Renal Physiol, February 1, 1998; 274(2): F405 - F412. [Abstract] [Full Text] [PDF] |
||||
| Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact |